The global Gabapentin market was valued at 1499.98 Million USD in 2020 and will grow with a CAGR of 1.77% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.Gabapentin was originally marketed under the brand name Neurontin and since it became generic, it has been marketed under many other brand names. An extended-release formulation of gabapentin for once-daily administration was introduced in 2011 for postherpetic neuralgia under the brand name Gralise. Gabapentin is used primarily to treat seizures and neuropathic pain. It is also commonly prescribed for many off-label uses, such as treatment of anxiety disorders, insomnia, and bipolar disorder. There are, however, concerns regarding the quality of the trials conducted and evidence for some such uses, especially in the case of its use as a mood stabilizer in bipolar disorder. In 2018, the global Gabapentin market size was 1430 million US$ and is forecast to 1630 million US in 2025, growing at a CAGR of 1.8% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Gabapentin.
By Market Verdors:
Pfizer
Assertio Therapeutics
TEVA
Mylan
Arbor Pharma
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Glenmark
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike
By Types:
Capsule
Tablet
By Applications:
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Gabapentin Market Size Analysis from 2022 to 2027
1.5.1 Global Gabapentin Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Gabapentin Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Gabapentin Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Gabapentin Industry Impact
Chapter 2 Global Gabapentin Competition by Types, Applications, and Top Regions and Countries
2.1 Global Gabapentin (Volume and Value) by Type
2.1.1 Global Gabapentin Consumption and Market Share by Type (2016-2021)
2.1.2 Global Gabapentin Revenue and Market Share by Type (2016-2021)
2.2 Global Gabapentin (Volume and Value) by Application
2.2.1 Global Gabapentin Consumption and Market Share by Application (2016-2021)
2.2.2 Global Gabapentin Revenue and Market Share by Application (2016-2021)
2.3 Global Gabapentin (Volume and Value) by Regions
2.3.1 Global Gabapentin Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Gabapentin Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Gabapentin Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Gabapentin Consumption by Regions (2016-2021)
4.2 North America Gabapentin Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Gabapentin Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Gabapentin Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Gabapentin Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Gabapentin Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Gabapentin Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Gabapentin Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Gabapentin Sales, Consumption, Export, Import (2016-2021)
4.10 South America Gabapentin Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Gabapentin Market Analysis
5.1 North America Gabapentin Consumption and Value Analysis
5.1.1 North America Gabapentin Market Under COVID-19
5.2 North America Gabapentin Consumption Volume by Types
5.3 North America Gabapentin Consumption Structure by Application
5.4 North America Gabapentin Consumption by Top Countries
5.4.1 United States Gabapentin Consumption Volume from 2016 to 2021
5.4.2 Canada Gabapentin Consumption Volume from 2016 to 2021
5.4.3 Mexico Gabapentin Consumption Volume from 2016 to 2021
Chapter 6 East Asia Gabapentin Market Analysis
6.1 East Asia Gabapentin Consumption and Value Analysis
6.1.1 East Asia Gabapentin Market Under COVID-19
6.2 East Asia Gabapentin Consumption Volume by Types
6.3 East Asia Gabapentin Consumption Structure by Application
6.4 East Asia Gabapentin Consumption by Top Countries
6.4.1 China Gabapentin Consumption Volume from 2016 to 2021
6.4.2 Japan Gabapentin Consumption Volume from 2016 to 2021
6.4.3 South Korea Gabapentin Consumption Volume from 2016 to 2021
Chapter 7 Europe Gabapentin Market Analysis
7.1 Europe Gabapentin Consumption and Value Analysis
7.1.1 Europe Gabapentin Market Under COVID-19
7.2 Europe Gabapentin Consumption Volume by Types
7.3 Europe Gabapentin Consumption Structure by Application
7.4 Europe Gabapentin Consumption by Top Countries
7.4.1 Germany Gabapentin Consumption Volume from 2016 to 2021
7.4.2 UK Gabapentin Consumption Volume from 2016 to 2021
7.4.3 France Gabapentin Consumption Volume from 2016 to 2021
7.4.4 Italy Gabapentin Consumption Volume from 2016 to 2021
7.4.5 Russia Gabapentin Consumption Volume from 2016 to 2021
7.4.6 Spain Gabapentin Consumption Volume from 2016 to 2021
7.4.7 Netherlands Gabapentin Consumption Volume from 2016 to 2021
7.4.8 Switzerland Gabapentin Consumption Volume from 2016 to 2021
7.4.9 Poland Gabapentin Consumption Volume from 2016 to 2021
Chapter 8 South Asia Gabapentin Market Analysis
8.1 South Asia Gabapentin Consumption and Value Analysis
8.1.1 South Asia Gabapentin Market Under COVID-19
8.2 South Asia Gabapentin Consumption Volume by Types
8.3 South Asia Gabapentin Consumption Structure by Application
8.4 South Asia Gabapentin Consumption by Top Countries
8.4.1 India Gabapentin Consumption Volume from 2016 to 2021
8.4.2 Pakistan Gabapentin Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Gabapentin Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Gabapentin Market Analysis
9.1 Southeast Asia Gabapentin Consumption and Value Analysis
9.1.1 Southeast Asia Gabapentin Market Under COVID-19
9.2 Southeast Asia Gabapentin Consumption Volume by Types
9.3 Southeast Asia Gabapentin Consumption Structure by Application
9.4 Southeast Asia Gabapentin Consumption by Top Countries
9.4.1 Indonesia Gabapentin Consumption Volume from 2016 to 2021
9.4.2 Thailand Gabapentin Consumption Volume from 2016 to 2021
9.4.3 Singapore Gabapentin Consumption Volume from 2016 to 2021
9.4.4 Malaysia Gabapentin Consumption Volume from 2016 to 2021
9.4.5 Philippines Gabapentin Consumption Volume from 2016 to 2021
9.4.6 Vietnam Gabapentin Consumption Volume from 2016 to 2021
9.4.7 Myanmar Gabapentin Consumption Volume from 2016 to 2021
Chapter 10 Middle East Gabapentin Market Analysis
10.1 Middle East Gabapentin Consumption and Value Analysis
10.1.1 Middle East Gabapentin Market Under COVID-19
10.2 Middle East Gabapentin Consumption Volume by Types
10.3 Middle East Gabapentin Consumption Structure by Application
10.4 Middle East Gabapentin Consumption by Top Countries
10.4.1 Turkey Gabapentin Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Gabapentin Consumption Volume from 2016 to 2021
10.4.3 Iran Gabapentin Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Gabapentin Consumption Volume from 2016 to 2021
10.4.5 Israel Gabapentin Consumption Volume from 2016 to 2021
10.4.6 Iraq Gabapentin Consumption Volume from 2016 to 2021
10.4.7 Qatar Gabapentin Consumption Volume from 2016 to 2021
10.4.8 Kuwait Gabapentin Consumption Volume from 2016 to 2021
10.4.9 Oman Gabapentin Consumption Volume from 2016 to 2021
Chapter 11 Africa Gabapentin Market Analysis
11.1 Africa Gabapentin Consumption and Value Analysis
11.1.1 Africa Gabapentin Market Under COVID-19
11.2 Africa Gabapentin Consumption Volume by Types
11.3 Africa Gabapentin Consumption Structure by Application
11.4 Africa Gabapentin Consumption by Top Countries
11.4.1 Nigeria Gabapentin Consumption Volume from 2016 to 2021
11.4.2 South Africa Gabapentin Consumption Volume from 2016 to 2021
11.4.3 Egypt Gabapentin Consumption Volume from 2016 to 2021
11.4.4 Algeria Gabapentin Consumption Volume from 2016 to 2021
11.4.5 Morocco Gabapentin Consumption Volume from 2016 to 2021
Chapter 12 Oceania Gabapentin Market Analysis
12.1 Oceania Gabapentin Consumption and Value Analysis
12.2 Oceania Gabapentin Consumption Volume by Types
12.3 Oceania Gabapentin Consumption Structure by Application
12.4 Oceania Gabapentin Consumption by Top Countries
12.4.1 Australia Gabapentin Consumption Volume from 2016 to 2021
12.4.2 New Zealand Gabapentin Consumption Volume from 2016 to 2021
Chapter 13 South America Gabapentin Market Analysis
13.1 South America Gabapentin Consumption and Value Analysis
13.1.1 South America Gabapentin Market Under COVID-19
13.2 South America Gabapentin Consumption Volume by Types
13.3 South America Gabapentin Consumption Structure by Application
13.4 South America Gabapentin Consumption Volume by Major Countries
13.4.1 Brazil Gabapentin Consumption Volume from 2016 to 2021
13.4.2 Argentina Gabapentin Consumption Volume from 2016 to 2021
13.4.3 Columbia Gabapentin Consumption Volume from 2016 to 2021
13.4.4 Chile Gabapentin Consumption Volume from 2016 to 2021
13.4.5 Venezuela Gabapentin Consumption Volume from 2016 to 2021
13.4.6 Peru Gabapentin Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Gabapentin Consumption Volume from 2016 to 2021
13.4.8 Ecuador Gabapentin Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Gabapentin Business
14.1 Pfizer
14.1.1 Pfizer Company Profile
14.1.2 Pfizer Gabapentin Product Specification
14.1.3 Pfizer Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Assertio Therapeutics
14.2.1 Assertio Therapeutics Company Profile
14.2.2 Assertio Therapeutics Gabapentin Product Specification
14.2.3 Assertio Therapeutics Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 TEVA
14.3.1 TEVA Company Profile
14.3.2 TEVA Gabapentin Product Specification
14.3.3 TEVA Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Mylan
14.4.1 Mylan Company Profile
14.4.2 Mylan Gabapentin Product Specification
14.4.3 Mylan Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Arbor Pharma
14.5.1 Arbor Pharma Company Profile
14.5.2 Arbor Pharma Gabapentin Product Specification
14.5.3 Arbor Pharma Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Novartis
14.6.1 Novartis Company Profile
14.6.2 Novartis Gabapentin Product Specification
14.6.3 Novartis Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Apotex
14.7.1 Apotex Company Profile
14.7.2 Apotex Gabapentin Product Specification
14.7.3 Apotex Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Sun Pharmaceutical
14.8.1 Sun Pharmaceutical Company Profile
14.8.2 Sun Pharmaceutical Gabapentin Product Specification
14.8.3 Sun Pharmaceutical Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Aurobindo Pharma
14.9.1 Aurobindo Pharma Company Profile
14.9.2 Aurobindo Pharma Gabapentin Product Specification
14.9.3 Aurobindo Pharma Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Intas
14.10.1 Intas Company Profile
14.10.2 Intas Gabapentin Product Specification
14.10.3 Intas Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Amneal
14.11.1 Amneal Company Profile
14.11.2 Amneal Gabapentin Product Specification
14.11.3 Amneal Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Marksans Pharma
14.12.1 Marksans Pharma Company Profile
14.12.2 Marksans Pharma Gabapentin Product Specification
14.12.3 Marksans Pharma Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 Glenmark
14.13.1 Glenmark Company Profile
14.13.2 Glenmark Gabapentin Product Specification
14.13.3 Glenmark Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 Alkem
14.14.1 Alkem Company Profile
14.14.2 Alkem Gabapentin Product Specification
14.14.3 Alkem Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.15 Jiangsu Enhua
14.15.1 Jiangsu Enhua Company Profile
14.15.2 Jiangsu Enhua Gabapentin Product Specification
14.15.3 Jiangsu Enhua Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.16 Jiangsu Hengrui
14.16.1 Jiangsu Hengrui Company Profile
14.16.2 Jiangsu Hengrui Gabapentin Product Specification
14.16.3 Jiangsu Hengrui Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.17 Sailike
14.17.1 Sailike Company Profile
14.17.2 Sailike Gabapentin Product Specification
14.17.3 Sailike Gabapentin Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Gabapentin Market Forecast (2022-2027)
15.1 Global Gabapentin Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Gabapentin Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Gabapentin Value and Growth Rate Forecast (2022-2027)
15.2 Global Gabapentin Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Gabapentin Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Gabapentin Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Gabapentin Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Gabapentin Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Gabapentin Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Gabapentin Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Gabapentin Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Gabapentin Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Gabapentin Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Gabapentin Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Gabapentin Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Gabapentin Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Gabapentin Consumption Forecast by Type (2022-2027)
15.3.2 Global Gabapentin Revenue Forecast by Type (2022-2027)
15.3.3 Global Gabapentin Price Forecast by Type (2022-2027)
15.4 Global Gabapentin Consumption Volume Forecast by Application (2022-2027)
15.5 Gabapentin Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Overview of the Global Gabapentin Drug Market:
The report discusses everything a marketer requires before investing in the global Gabapentin Drug Market during the forecast period 2023-2030. It provides detailed ins...
The global Gabapentin Enacarbil market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this...
Summary
The report forecast global Gabapentin Enacarbil market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021E-2026F due to coronavirus situation.
The report offers detailed coverage of Gabapentin Enacarbil industry and main market trends with i...
Summary
The report forecast global Gabapentin Drug market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021E-2026F due to coronavirus situation.
The report offers detailed coverage of Gabapentin Drug industry and main market trends with impact of c...
The global Gabapentin market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field eva...
The global Gabapentin Drug market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this fiel...
Summary
Gabapentin is an anti-epileptic medication, also called an anticonvulsant. It affects chemicals and nerves in the body that are involved in the cause of seizures and some types of pain.
The report forecast global Gabapentin market to grow to reach xxx Million USD in 2020 w...
The global Gabapentin market was valued at 1499.98 Million USD in 2020 and will grow with a CAGR of 1.77% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in t...
The research team projects that the Gabapentin Drug market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.
The prime objective of this report is to help the user u...
The research team projects that the Gabapentin Enacarbil market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.
The prime objective of this report is to help the u...